Search

everythinglearnresearchcommunity

for

Search:↓

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Six genetic conditions are often linked to complete scalp hair loss in children.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib is effective and safe for treating alopecia areata.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

A girl with severe hair loss saw hair regrowth after using cannabis.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

The document describes a rare case of IFAP syndrome, a genetic condition with symptoms of hair loss, light sensitivity, and scaly skin.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

An arthritis drug helped a person with severe hair loss regrow their hair.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Alopecia areata in infants may be more common than previously thought.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Most patients with small patches of hair loss usually regrow hair.

Low iron levels may be linked to some types of hair loss in women.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.